A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
NCT03100825
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
QVM149
Sponsor
Novartis Pharmaceuticals